Table 4 Deaths (%) of all SARS-Cov2 positive cases (18 + Ages) after Jan 30th.
From: Post-vaccination outcomes in association with four COVID-19 vaccines in the Kingdom of Bahrain
Vaccine type | Total rate (death) | > 50 rate (death) | < 50 rate (death) | ||||||
|---|---|---|---|---|---|---|---|---|---|
Rate (total) | LCL UCL | OR | Rate (total) | LCL UCL | OR | Rate (total) | LCL UCL | OR | |
Unvaccinated | 1.33 (810) | 1.21 1.45 | NA | 5.65 (593) | 5.09 6.25 | NA | 0.43 (217) | 0.36 (0.51) | NA |
Sinopharm | 0.46 (112) | 0.36 0.58 | 2.9 | 1.53 (103) | 1.18 1.95 | 3.8 | 0.05 (9) | 0.02 0.11 | 8.4 |
Sputnik V | 0.09 (3) | 0.01 0.29 | 15.4 | 0.79 (3) | 0.13 2.65 | 7.5 | 0 (0) | 0.00 0.13 | inf |
Pfizer-BioNtech | 0.15 (3) | 0.02 0.50 | 9.0 | 0.69 (3) | 0.11 2.32 | 8.6 | 0 (0) | 0.00 0.25 | *inf |
Covishield | 0.03 (1) | 0.00 0.22 | 39.7 | 0 (0) | 0.00 0.68 | inf | 0.04 (1) | 0.00 0.27 | **10.3 |
